Allianz Asset Management’s Pacific Biosciences PACB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-50,096
Closed -$1.02M 2593
2021
Q4
$1.02M Sell
50,096
-7,881
-14% -$190K ﹤0.01% 1900
2021
Q3
$1.48M Buy
57,977
+41,450
+251% +$1.23M ﹤0.01% 1766
2021
Q2
$578K Sell
16,527
-45,191
-73% -$1.31M ﹤0.01% 1979
2021
Q1
$2.06M Sell
61,718
-21,462
-26% -$751K ﹤0.01% 1398
2020
Q4
$2.16M Sell
83,180
-84,500
-50% -$1.44M ﹤0.01% 1294
2020
Q3
$1.66M Buy
+167,680
New +$965K ﹤0.01% 1313
2019
Q1
Sell
-461,225
Closed -$3.41M 2755
2018
Q4
$3.41M Buy
+461,225
New +$2.92M ﹤0.01% 1566
2017
Q2
Sell
-396,075
Closed -$2.05M 2668
2017
Q1
$2.05M Sell
396,075
-22,000
-5% -$108K ﹤0.01% 1992
2016
Q4
$1.59M Sell
418,075
-175,031
-30% -$1.27M ﹤0.01% 2049
2016
Q3
$5.31M Buy
+593,106
New +$4.96M 0.01% 1593

Other funds holding PACB